Addus HomeCare Corporation (NASDAQ:ADUS – Get Free Report) EVP Sean Gaffney sold 817 shares of Addus HomeCare stock in a transaction dated Tuesday, February 24th. The shares were sold at an average price of $106.98, for a total transaction of $87,402.66. Following the completion of the sale, the executive vice president owned 20,522 shares in the company, valued at approximately $2,195,443.56. This trade represents a 3.83% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.
Sean Gaffney also recently made the following trade(s):
- On Wednesday, February 25th, Sean Gaffney sold 442 shares of Addus HomeCare stock. The shares were sold at an average price of $105.36, for a total transaction of $46,569.12.
Addus HomeCare Price Performance
NASDAQ:ADUS opened at $103.53 on Friday. The firm has a market cap of $1.92 billion, a P/E ratio of 19.87, a price-to-earnings-growth ratio of 1.44 and a beta of 0.91. The stock has a 50 day moving average of $109.22 and a two-hundred day moving average of $112.95. Addus HomeCare Corporation has a 12 month low of $88.96 and a 12 month high of $124.43. The company has a current ratio of 1.80, a quick ratio of 1.66 and a debt-to-equity ratio of 0.11.
Key Stories Impacting Addus HomeCare
- Positive Sentiment: Large institutional holders have been adding to positions in recent quarters, which provides a steady shareholder base and underlying demand. MarketBeat ADUS Institutional Holdings
- Positive Sentiment: Stephens kept an “Overweight” rating on ADUS and a $135 price target (trimmed from $140), signaling continued analyst conviction even after the cut. That backing can limit downside over the medium term. Stephens PT story
- Neutral Sentiment: Short‑interest figures are inconsistent across feeds (some reports show zero or NaN, others show a material rise). This data noise makes it hard to interpret immediate short pressure — confirm with FINRA/exchange data before acting. MarketBeat short interest
- Negative Sentiment: Significant insider selling across Feb. 24–25: CEO R. Dirk Allison and multiple EVPs sold several thousand shares in aggregate (CEO filings disclosed to the SEC). Large, concentrated insider sales are weighing on sentiment and likely contributed to today’s weakness. CEO SEC filing
- Negative Sentiment: Media flagged a “pessimistic forecast” narrative after Stephens trimmed its target, which can reinforce short‑term selling despite the retained Overweight rating. That coverage likely amplified intra‑day pressure. AmericanBankingNews piece
- Negative Sentiment: Smaller insider sales (e.g., EVP Cliff Blessing) were also reported; while individually minor, the wave of coordinated filings increases headline risk and may trigger mechanical selling. InsiderTrades alert
Analyst Ratings Changes
A number of equities research analysts have recently commented on ADUS shares. Truist Financial set a $135.00 target price on shares of Addus HomeCare and gave the company a “buy” rating in a research report on Wednesday, January 7th. KeyCorp reaffirmed an “overweight” rating on shares of Addus HomeCare in a research note on Wednesday. Royal Bank Of Canada reiterated an “outperform” rating and set a $139.00 price objective on shares of Addus HomeCare in a research report on Wednesday. Stephens lowered their price objective on Addus HomeCare from $140.00 to $135.00 and set an “overweight” rating on the stock in a research note on Wednesday. Finally, Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Addus HomeCare in a research note on Wednesday, January 21st. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, Addus HomeCare currently has an average rating of “Moderate Buy” and an average price target of $134.33.
Get Our Latest Analysis on Addus HomeCare
Institutional Inflows and Outflows
Hedge funds have recently added to or reduced their stakes in the business. Hohimer Wealth Management LLC increased its stake in Addus HomeCare by 3.4% during the third quarter. Hohimer Wealth Management LLC now owns 2,709 shares of the company’s stock worth $320,000 after acquiring an additional 88 shares during the last quarter. Ameritas Investment Partners Inc. grew its holdings in shares of Addus HomeCare by 5.0% during the 2nd quarter. Ameritas Investment Partners Inc. now owns 1,854 shares of the company’s stock worth $214,000 after purchasing an additional 89 shares during the period. Amalgamated Bank increased its position in shares of Addus HomeCare by 1.8% during the 3rd quarter. Amalgamated Bank now owns 5,240 shares of the company’s stock worth $618,000 after purchasing an additional 93 shares during the last quarter. Oregon Public Employees Retirement Fund raised its holdings in Addus HomeCare by 2.5% in the 4th quarter. Oregon Public Employees Retirement Fund now owns 4,153 shares of the company’s stock valued at $446,000 after buying an additional 103 shares during the period. Finally, GAMMA Investing LLC lifted its position in Addus HomeCare by 6.3% in the third quarter. GAMMA Investing LLC now owns 1,778 shares of the company’s stock valued at $210,000 after buying an additional 105 shares during the last quarter. 95.35% of the stock is currently owned by hedge funds and other institutional investors.
About Addus HomeCare
Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.
The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.
Featured Stories
- Five stocks we like better than Addus HomeCare
- The gold chart Wall Street is terrified of…
- This makes me furious
- America’s 1776 happening again
- Buy this Gold Stock Before May 2026
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.
